Lactose Monohydrate & LACTOSE MONOHYDRATE Excipient Use in Intramuscular Oral Dosage Forms

Lactose Monohydrate

FDA Inactive Ingredient Details, DESCRIPTION

Suppliers

25 Listed Products, 2 Microlex e.U, 1 Nanjing Well Pharmaceutical, 4 Gangwal Healthcare, 2 DFE Pharma, 14 Kerry, 2 Sigachi Industries

REGULATORY FILINGS

8 Suppliers, 8 USDMF, 1 NDC API

SOLUTIONS BY APPLICATIONS

18 Fillers, Diluents & Binders, 7 Direct Compression, 4 Granulation, 4 Co-Processed Excipients, 1 Parenteral, 1 Disintegrants & Superdisintegrants

ANALYTICAL SOLUTION(s)

1 Other Ref. Standards

1 Other Ref. Standards

FINISHED FORMULATIONS

1898 ORAL, 1502 TABLET, 211 CAPSULE, 165 TABLET, EXTENDED RELEASE, 52 ORAL-28, 32 TABLET, DELAYED RELEASE, 21 SUBLINGUAL, 16 CAPSULE, EXTENDED RELEASE, 16 INJECTABLE, 15 TABLET, CHEWABLE, 13 INHALATION, 12 INTRAVENOUS, 12 POWDER, 8 TABLET, ORALLY DISINTEGRATING, 7 FOR SUSPENSION, 7 INJECTION, 7 SOLUTION, 6 CAPSULE, DELAYED RELEASE, 6 ORAL-21, 5 CAPSULE, DELAYED REL PELLETS, 4 VAGINAL, 2 GRANULE, 2 POWDER, METERED, 2 SUSPENSION, 2 TABLET, FOR SUSPENSION, 1 BUCCAL, 1 CONCENTRATE, 1 CREAM, 1 EMULSION, 1 INJECTABLE, TABLET, 1 INTRAMUSCULAR, ORAL, 1 SUPPOSITORY